{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"vip-herniated-disc","urls":{"read":"https://miscsubjects.com/api/articles/vip-herniated-disc/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/vip-herniated-disc/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/vip-herniated-disc/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/vip-herniated-disc/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/vip-herniated-disc/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/vip-herniated-disc/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/vip-herniated-disc/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"vip-herniated-disc","title":"VIP for Herniated Disc: Evidence on Repair Pathways","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:43:24.493Z","body_excerpt":"## What's breaking down if you have Herniated disc\n\nA herniation is when disc material pushes through the outer ring. Often starts from degenerative disc changes — weakened annulus tears under load. The herniation itself is an acute event on top of chronic degeneration. Nerve compression or chemical irritation causes pain; the disc structure is still compromised.\n\nDegenerative layers include:\n- Disc matrix: Collagen and proteoglycans degrade; disc height drops.\n- Inflammation: Chronic inflammatory signaling without resolution stalls repair.\n- Nerves: Nerve roots get irritated or compressed as disc bulges.\n- Blood supply: Discs are avascular — repair depends on diffusion; less supply = slower repair.\n\nIf breakdown outruns repair in any layer, the condition persists. Peptides here are studied for specific repair pathways rather than symptom suppression.\n\n## Why VIP might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **VIP**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\n\nVIP is studied in the immune/autonomic layer. In donor nucleus pulposus tissue, VIP receptor levels drop as degeneration advances. Inhibiting the receptor reduces type II collagen and aggrecan production. In mice treated with VIP for four weeks, MRI showed slowed disc degeneration progression versus controls, plus higher aggrecan levels. This suggests VIP may support disc matrix maintenance via FGF18/FGFR2-Akt signaling in preclinical models.\n\n## Why BPC-157 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\nBPC-157 is studied in the structure/tissue layer. Animal models show effects on angiogenesis and tissue turnover after injury. Direct herniated disc studies in humans are absent.\n\n## Why TB-500 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Inflammation — Chronic inflammatory signaling without resolution stalls repair.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\nTB-500 is studied in the inflammation clearance/repair-cell migration layer. In human disc cell cultures, exogenous thymosin β4 reduced apoptosis. Animal models link it to cell migration and blood supply in various injuries.\n\n## Why ARA-290 might help you\n\n1. You have **Herniated disc** — breakdown is outpacing repair.\n2. **Layer breaking down:** Nerves — Nerve roots get irritated or compressed as disc bulges.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\nARA-290 is studied in the nerve/innervation layer. Human trials in sarcoidosis-associated small fiber neuropathy showed pain reduction and improved nerve fiber density. Rat sciatic nerve injury models indicate NLRP3 inflammasome inhibition and functional recovery.\n\n## How these fit together\n\nThree degeneration layers — disc/tissue, inflammation/repair cells, nerves — map to three repair pathways in the recovery stack.\n- **VIP** → immune / auto","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c5","text":"ARA-290 reduced neuropathic pain and increased corneal nerve fiber density in human sarcoidosis patients.","tier":"human","weight":0.8,"section":"Why ARA-290 might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s4"],"source_status":"sourced","why_material":"Human trial evidence for nerve repair effects.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c6","text":"No randomized controlled human trials exist for VIP, BPC-157, TB-500, or ARA-290 in herniated disc.","tier":"human","weight":0.8,"section":"What we do not know","slot":null,"interaction_risk":false,"status":"active","source_ids":[],"source_status":"unsourced","why_material":"Gap in direct clinical evidence for the condition.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c3","text":"BPC-157 improved functional recovery after spinal cord injury in rats.","tier":"preclinical","weight":0.5,"section":"Why BPC-157 might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Supports tissue repair potential in spinal models.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c4","text":"Exogenous thymosin β4 reduced apoptosis in human disc cell cultures.","tier":"mechanistic","weight":0.3,"section":"Why TB-500 might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s3"],"source_status":"sourced","why_material":"Direct effect on disc cells in vitro.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c1","text":"In human donor nucleus pulposus tissue, VIP receptor levels decline as disc degeneration increases.","tier":"human","weight":0.8,"section":"Why VIP might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Direct observation in ex vivo human tissue links VIP signaling to degeneration severity.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c2","text":"Mice treated with VIP for four weeks showed slowed disc degeneration on MRI and increased aggrecan versus controls.","tier":"preclinical","weight":0.5,"section":"Why VIP might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s1"],"source_status":"sourced","why_material":"Animal model demonstrates protective effect on disc matrix.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38047500/","title":"Sympathetic Neurotransmitter, VIP, Delays Intervertebral Disc Degeneration via FGF18/FGFR2-Mediated Activation of Akt Signaling Pathway","quote":"Here, this study aimed to investigate the expression of postganglionic sympathetic nerve fiber-derived vasoactive intestinal peptide (VIP) ...","summary":"Human donor tissue and mouse model study on VIP in disc degeneration.","claim_ids":["c1","c2"],"link_status":"ok","quote_status":"unverified","hash":"5bc2f0afdb75f259f785a7f79577ef1c1eb365ea6f45968b41d6071cdee4697b"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats","quote":"We focused on the therapeutic effects of the stable gastric pentadecapeptide BPC 157 in spinal cord injury using a rat model.","summary":"Rat spinal cord injury model with BPC-157.","claim_ids":["c3"],"link_status":"ok","quote_status":"verified","hash":"3eda2c49567d693329c1803160a32183b642546bf87b4a63ad4ebcfc11cdae5c"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2886502/","title":"Exogenous thymosin β4 prevents apoptosis in human intervertebral disc cells","quote":"A significant reduction in disc cell apoptosis occurred after TB4 treatment.","summary":"In vitro study on human disc cells.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"928647b5b1365b44215fee264660292b9175a4f90ccf795f2f5afb12a2dc6179"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3883966/","title":"ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain","quote":"ARA 290 is a small peptide engineered to activate the innate repair receptor that antagonizes inflammatory processes and stimulates tissue repair.","summary":"Human trial in sarcoidosis neuropathy.","claim_ids":["c5"],"link_status":"ok","quote_status":"verified","hash":"9a5d9ae58f167d83aff00f1a1a32a5302e9c5689b06f926c463a1295652ca47b"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/38047500/","title":"Sympathetic Neurotransmitter, VIP, Delays Intervertebral Disc Degeneration via FGF18/FGFR2-Mediated Activation of Akt Signaling Pathway","quote":"Here, this study aimed to investigate the expression of postganglionic sympathetic nerve fiber-derived vasoactive intestinal peptide (VIP) ...","summary":"Human donor tissue and mouse model study on VIP in disc degeneration.","claim_ids":["c1","c2"],"link_status":"ok","quote_status":"unverified","hash":"5bc2f0afdb75f259f785a7f79577ef1c1eb365ea6f45968b41d6071cdee4697b"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31266512/","title":"Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats","quote":"We focused on the therapeutic effects of the stable gastric pentadecapeptide BPC 157 in spinal cord injury using a rat model.","summary":"Rat spinal cord injury model with BPC-157.","claim_ids":["c3"],"link_status":"ok","quote_status":"verified","hash":"3eda2c49567d693329c1803160a32183b642546bf87b4a63ad4ebcfc11cdae5c"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2886502/","title":"Exogenous thymosin β4 prevents apoptosis in human intervertebral disc cells","quote":"A significant reduction in disc cell apoptosis occurred after TB4 treatment.","summary":"In vitro study on human disc cells.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"928647b5b1365b44215fee264660292b9175a4f90ccf795f2f5afb12a2dc6179"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3883966/","title":"ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain","quote":"ARA 290 is a small peptide engineered to activate the innate repair receptor that antagonizes inflammatory processes and stimulates tissue repair.","summary":"Human trial in sarcoidosis neuropathy.","claim_ids":["c5"],"link_status":"ok","quote_status":"verified","hash":"9a5d9ae58f167d83aff00f1a1a32a5302e9c5689b06f926c463a1295652ca47b"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"vip-herniated-disc","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":6,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":6,"claims_total":6,"sources":4,"anecdotal":0,"scientific":4,"user_reports":0,"questions":0,"evidence_ingests":0}}